...
首页> 外文期刊>European journal of inorganic chemistry >Anticancer Activity and Mode of Action of Copper(II)-Bis(thiosemicarbazonato) Complexes with Pendant Nitrogen Heterocycles
【24h】

Anticancer Activity and Mode of Action of Copper(II)-Bis(thiosemicarbazonato) Complexes with Pendant Nitrogen Heterocycles

机译:铜(II)-BIS(硫代喹甲胞质)复合物的抗癌活动和铜(II)的作用方式与侧氮杂杂环

获取原文
获取原文并翻译 | 示例

摘要

Exploring the potential of bis(thiosemicarbazones) (BTSC), a new family of BTSC ligands derived from GTSM (glyoxal-bis(N4-methylthiosemicarbazonato) and respective (CuBTSC)-B-II complexes were synthesized. These complexes, having pendant nitrogen heterocycles, exhibited increased water-solubility, lower lipophilicity at physiological pH and more negative Cu(II)/Cu(I) redox potential, when compared with the parental complex. The cytotoxic evaluation performed in a panel of cancer cells lines showed an important effect of the metal complexation, and furthermore correlated well with the cellular uptake of the compounds, which was determined using their Cu-64 congeners. The radiolabelling of the complexes also allowed more detailed uptake studies, with the results suggesting an active transport or facilitated diffusion mechanism for the cellular uptake of (64)CuGTSMpip and (64)CuGTSMmor, with pendant piperidine and morpholine rings, respectively. Additionally, a comparative study with the corresponding Cu(II) complexes derived from ATSM (diacetyl-bis(N-4-methylthiosemicarbazonato) that we have previously described, demonstrated a clear difference in their lysosomotropic properties in particular for the piperidine derivatives. From this study, CuGTSMpip emerged as the most promising compound to be further evaluated as an anticancer metallodrug.
机译:为了探索双(氨基硫脲)(BTSC)的潜力,合成了一个新的BTSC配体家族,该家族由GTSM(乙二醛双(N4-甲基氨基硫脲)和相应的(CuBTSC)-B-II配合物衍生而来。与母体配合物相比,这些含侧氮杂环的配合物表现出更高的水溶性、更低的生理pH亲油性和更负的Cu(II)/Cu(I)氧化还原电位。在一组癌细胞系中进行的细胞毒性评估显示了金属络合的重要作用,并且与化合物的细胞摄取密切相关,这是使用其Cu-64同系物测定的。配合物的放射性标记也允许进行更详细的摄取研究,结果表明,(64)CuGTSMpip和(64)CuGTSMmor的细胞摄取分别具有侧链哌啶环和吗啉环,具有主动运输或促进扩散机制。此外,与我们之前描述的ATSM(二乙酰基双(N-4-甲基氨基硫脲)衍生的相应铜(II)配合物的比较研究表明,它们的溶酶体性质明显不同,尤其是对于哌啶衍生物。从这项研究中,CuGTSMpip成为最有希望作为抗癌药物进一步评估的化合物。

著录项

  • 来源
  • 作者单位

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

    Univ Coimbra Inst Ciencias Nucl Aplicadas Saude CIBIT ICNAS Coimbra Portugal;

    Univ Coimbra Inst Ciencias Nucl Aplicadas Saude CIBIT ICNAS Coimbra Portugal;

    Univ Coimbra Inst Ciencias Nucl Aplicadas Saude CIBIT ICNAS Coimbra Portugal;

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

    Univ Lisbon Inst Super Tecn Ctr Ciencias &

    Tecnol Nucl C2TN Estr Nacl 10 P-2695066 Bobadela Lrs Portugal;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 无机化学 ;
  • 关键词

    Antitumor agents; Bis(thiosemicarbazone)s; Cellular studies; Copper; Metallodrugs;

    机译:抗肿瘤药物;双(氨基硫脲)s;细胞研究;铜金属药物;

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号